Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Energean profits rise despite revenue decline

(Sharecast News) - Energean reported a rise in half-year profits despite a fall in revenue on Thursday, as strong summer demand for its Israeli gas assets helped offset the impact of a temporary production halt and weaker oil prices. The eastern Mediterranean-focused energy group said profit after tax rose 24% to $110m in the six months to 30 June, up from $89m a year earlier, aided by the absence of impairments that had weighed on the prior period.

Earnings per share climbed 25% to $0.60.

Revenue declined 7% to $804m, while adjusted EBITDAX fell 11% to $505m, reflecting lower production volumes and a drop in realised oil prices.

Production averaged 138,000 barrels of oil equivalent per day (kboed) in the first half, down 5% on last year after a two-week suspension of Israeli operations in June ordered by the Ministry of Energy and Infrastructure due to regional geopolitical tensions.

Output had since rebounded, with group production averaging 147 kboed year-to-date and reaching 178 kboed in August alone.

"Our business has remained resilient, despite the external geopolitical and market pressures, underpinned by disciplined capital management and cost control, a clear focus on long-term value creation and delivery of operational excellence," said chief executive Mathios Rigas.

"In August alone group production was 178 kboed, showcasing strong summer demand for our gas in Israel and strong performance of the Energean Power FPSO."

Energean highlighted progress on a series of strategic projects, including securing over $4bn in new long-term gas contracts in Israel, which lifted the total value of contracted gas to about $20bn over the next two decades.

The company also said its Katlan gas development remained on schedule and budget for first production in 2027, while a final investment decision had been taken on the Irena gas field offshore Croatia.

The group declared a quarterly dividend of $0.30 per share, part of a $110m return to shareholders during the period.

Net debt stood at $3bn at the half-year, up from $2.95bn at the end of 2024, while cash and cash equivalents rose to $487m.

Energean maintained full-year capital expenditure guidance at $480m to $520m but trimmed production guidance to between 145 and 155 kboed to reflect the earlier Israeli shutdown.

Rigas said the company would focus on "reliable production and sales to the domestic market" in Israel while pursuing export opportunities, continuing to evaluate organic and inorganic growth options, and maximising shareholder value through dividends and deleveraging.

"We are excited by the opportunities before us and remain committed to delivering long-term value across all areas of our business," he said.

At 0910 BST, shares in Energean were up 1.4% at 907p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.